| IPA for Kory Johnson |
Contract |
30,346.00 |
Research |
Ayman Fanous |
COM Phx Psychiatry |
12/2023 |
| IPA for Vladimir Vladimirov |
Contract |
34,997.00 |
Research |
Ayman Fanous |
COM Phx Psychiatry |
12/2023 |
| Oncology Summer Internship Host Agreement |
Grant |
5,000.00 |
Other Sponsored Activity |
Jacob Schwartz |
Cancer Center Division |
12/2023 |
| Patient-Based Postmortem Fibroblast Banking for Translational Research |
Contract |
20,000.00 |
Research |
Lalitha Madhavan |
Neurology |
12/2023 |
| Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease |
Contract |
597,627.00 |
Clinical Trial |
Paul Larson |
Neurosurgery |
12/2023 |
| Project Washington |
Contract |
87,888.00 |
Research |
Kelly Reynolds |
Community Environment & Policy |
12/2023 |
| PVAHCS IPA for Michael Kuhns |
Contract |
11,835.00 |
Research |
Karen Hastings |
COM Phx Basic Medical Sci |
12/2023 |
| Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators |
Grant |
2,955,015.00 |
Research |
Christopher Banek |
Physiology |
12/2023 |
| RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease |
Grant |
3,939,748.00 |
Research |
Mingyu Liang |
Physiology |
12/2023 |
| SAVAHCS IPA for Victoria Curfman |
Contract |
45,303.00 |
Research |
Mohab Ibrahim |
Anesthesiology |
12/2023 |
| Sex-specific Myofilament Dysfunction in Postmenopausal HFpEF |
Grant |
2,245,231.00 |
Research |
Methajit Methawasin |
Cellular & Molecular Medicine |
12/2023 |
| T Cell Sculpting of the Neoantigen Landscape in Cutaneous Squamous Cell Carcinoma |
Grant |
300,000.00 |
Research |
Karen Hastings |
COM Phx Dermatology |
12/2023 |
| A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) |
Contract |
749,783.32 |
Clinical Trial |
David Labiner |
Neurology |
11/2023 |
| A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension |
Contract |
235,166.76 |
Clinical Trial |
Nafis Shamsid-Deen |
COM Phx Internal Medicine |
11/2023 |
| A Phase 2a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALT-100 in Patients With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) |
Contract |
369,191.00 |
Clinical Trial |
Zachary Hernandez |
COM Phx Internal Medicine |
11/2023 |
| A Phase 3, Randomized, Open-label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-cell Lymphoma (DLB |
Contract |
1,097,975.93 |
Clinical Trial |
Abhijeet Kumar |
Cancer Center Division |
11/2023 |
| A Phase 4, Global, Prospective, Open label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clin |
Contract |
169,895.50 |
Clinical Trial |
Sasha Taleban |
Medicine |
11/2023 |
| A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec |
Contract |
1,286,672.52 |
Clinical Trial |
Christian Bime |
Medicine |
11/2023 |
| Accelerated Insulin Absorption by Administration Through a Miniature Subcutaneously Implanted Vascularized Chamber |
Grant |
99,360.00 |
Research |
Klearchos Papas |
Surgery |
11/2023 |
| Achieving Equity in Farmworker Health Through Community-Led Research |
Contract |
445,438.00 |
Research |
Maia Ingram |
Health Promotion Sciences |
11/2023 |
